The FDA has cleared a multiplex polymerase chain reaction test designed to detect 11 clinically relevant gastrointestinal pathogens from a single stool sample.The Xpert GI Panel (Cepheid) can identify ...
Cepheid has received clearance from the US Food and Drug Administration (FDA) for its Xpert GI Panel, a multiplex polymerase chain reaction (PCR) gastrointestinal (GI) pathogen testing solution. The ...
SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode, a leader in molecular diagnostics panel testing, is excited to announce a significant enhancement to its BioCode ® Gastrointestinal Pathogen ...
Background. Molecular syndromic diagnostic panels can enhance pathogen identification in the approximately 2–4 billion episodes of acute gastroenteritis that occur annually worldwide. However, the ...
Join us for a compelling webinar that delves into gastrointestinal pathogen diagnostics and the crucial role of targeted testing options in routine patient care. A Microbiology and Virology Medical ...
BEVERLY, Mass., Aug. 17, 2022 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), an innovative, molecular ...
SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode now offers STI + Resistance Panel on the BioCode® MDx-3000 system for research use only (RUO). Applied BioCode Inc., a pioneer in molecular ...
Following the first stay-at-home orders issued in the U.S. to curb the spread of COVID-19, gastrointestinal viruses such as norovirus, rotavirus and adenovirus all but disappeared from California ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results